Clinical trial · Observational
Examining a Common Complaint of Women Who Receive Chemotherapy for Breast Cancer- Cognitive Difficulty
Neurocognitive Impairment in Women With Early Stage Breast Cancer
NCT01553097CI-TRIAL-00016357completedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
This longitudinal project will investigate a common complaint of women who receive chemotherapy for breast cancer- cognitive difficulty. The relationships of fatigue, stress, and depression to cognitive difficulties will be examined. The findings should lead to interventions to decrease the effects of these problematic side effects.
Conditions
Conditions (3)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Breast Cancer | Malignant Breast Neoplasm | CURATED_EXACT | 0.92 |
| Neurocognitive Impairment | — | UNRESOLVED | — |
| Quality of Life | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Neurocognitive impairment observation | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (3)
- label
- women with stage I or II BC with adjuvant chemotherapy
- description
- women with Stage I or II BC who 1. have undergone surgical treatment (biopsy, lumpectomy or mastectomy) and; 2. will be receiving adjuvant chemotherapy
- interventionNames
- Other: Neurocognitive impairment observation
- label
- women with Stage I or II BC without adjuvant therapy
- description
- Women with stage I or II BC who 1. Have undergone surgical treatment (biopsy, lumpectomy or mastectomy) \\ 2. will not be receiving adjuvant chemotherapy
- interventionNames
- Other: Neurocognitive impairment observation
- label
- Healthy control
- description
- healthy education-age-matched women without cancer
- interventionNames
Eligibility
Eligibility (as posted)
- Sex
- Female
- Minimum age
- 21 Years
Show eligibility criteria text
Inclusion Criteria: * read and speak English * be physically able to take the computerized test (press the keyboard space bar and numerical keys "1" and "2" without difficulty) * have an ECOG Performance Status score \< 2.154 * capable of providing informed consent. Exclusion Criteria: * psychiatric impairment, such as organic brain disorders, mental retardation, active psychoses or dissociative disorders, or unstable and/or severe depressive illness.
References
Publications (0)
Data not yet available
No reference posted for this study.